查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1572446

药物管理系统市场、机会、成长动力、产业趋势分析与预测，2024-2032

Medication Management Systems Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 160 Pages | 商品交期: 2-3个工作天内

价格
简介目录

在医疗技术进步、老年人口增加以及慢性病盛行率上升的推动下，全球药物管理系统市场从 2024 年到 2032 年将呈现 9.8% 的复合年增长率。此外，电子健康记录 (EHR) 和电子处方的日益普及进一步推动了这一增长。

随着糖尿病和高血压等慢性病变得越来越普遍，对长期药物治疗的需求也随之增加。电子处方（e-prescribing）和电子健康记录（EHR）在推动药物管理系统产业方面发挥关键作用。这些技术确保无缝的用药资讯集成，增强医疗保健提供者、药房和患者之间的沟通，并保证准确、及时的用药管理。

药物管理系统市场根据软体类型、部署模式、最终用途和区域进行分类。

市场将软体类型分为临床决策支援系统解决方案（CDSS）、库存管理和供应链管理软体、电脑化医嘱输入（CPOE）、分流药物管理、管理软体、保证系统软体和其他软体类型。 2023 年，临床决策支援系统解决方案 (CDSS) 部门以 11 亿美元的收入领先。 CDSS 解决方案旨在透过在药物处方和配药期间为医疗保健专业人员提供即时、基于证据的指导来减少用药错误。这些系统可以通知提供者潜在的药物交互作用、过敏和禁忌症，从而避免有害的错误。鑑于医疗保健领域对用药错误的持续关注，CDSS 在药物管理中的日益采用凸显了其日益增长的重要性。

药物管理系统市场将部署模式分为基于云端的解决方案、本地解决方案和基于网路的解决方案。 2023 年，基于云端的细分市场以 48% 的份额引领市场。基于云端的药物管理系统提供无与伦比的可扩展性。这使得医疗保健提供者，从小型诊所到广阔的医院网络，能够根据需求调整他们的服务，而无需大量的前期基础设施投资。这种适应性是基于云端的解决方案采用激增的主要原因。

此外，基于云端的系统无需昂贵的本地硬体、维护和 IT 支持，从而为医疗保健提供者节省大量成本。组织可以过渡到基于订阅的模式，只需为他们使用的服务付费，而不是投资实体伺服器和软体授权。这种财务优势，特别是对于规模较小的提供者或预算紧张的提供者来说，将进一步推动该细分市场的成长。

2023年，北美药物管理系统市场规模达17亿美元，预计2024年至2032年复合年增长率为9.5%。这种先进的设置，加上早期采用药物管理系统等创新解决方案的趋势，凸显了市场的成长。该地区慢性病盛行率高，需要复杂的用药方案，这进一步强调了这些系统在确保依从性和尽量减少用药错误方面的重要性。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 用药错误不断增加和病人安全需求
      • 医疗保健 IT 解决方案的采用率不断提高
      • 提高医院和药局的自动化程度
    • 产业陷阱与挑战
      • 实施和维护成本高
  • 成长潜力分析
  • 监管环境
  • 技术景观
  • 主要市场趋势
  • 波特的分析
  • PESTEL分析
  • 差距分析
  • 未来市场趋势

第 4 章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按软体类型，2021 - 2032 年

  • 主要趋势
  • 临床决策支援系统解决方案（CDSS）
  • 库存管理和供应链管理软体
  • 电脑化医嘱输入 (CPOE)
  • 药物转移管理
  • 管理软体
    • 条码用药记录
    • 电子用药记录
  • 保障系统软体
  • 其他软体类型

第 6 章：市场估计与预测：按部署模式，2021 - 2032 年

  • 主要趋势
  • 基于云端
  • 本地部署
  • 基于网路

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

  • 主要趋势
  • 医院
  • 药局
  • 门诊手术中心
  • 其他最终用户

第 8 章：市场估计与预测：按地区划分，2021 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第 9 章：公司简介

  • Becton, Dickinson and Company
  • Bluesight
  • Capsa Healthcare
  • eAgile Inc.
  • Epic Systems Corporation
  • GE HealthCare Technologies Inc.
  • GUARDIAN RFID
  • Impinj, Inc.
  • MCKESSON CORPORATION
  • Omnicell, Inc.
  • Oracle Corporation
  • RMS Omega
  • Swisslog Healthcare
  • Veradigm LLC
  • Yankee Alliance LLC.
简介目录
Product Code: 10832

The Global Medication Management Systems Market will exhibit a 9.8% CAGR from 2024 to 2032, driven by advancements in medical technology, a rising geriatric population, and the increasing prevalence of chronic diseases. Additionally, the growing adoption of electronic health records (EHRs) and e-prescribing further fuels this growth.

As chronic diseases like diabetes and hypertension become more prevalent, the demand for long-term medication therapy intensifies. Electronic prescribing (e-prescribing) and electronic health records (EHRs) play pivotal roles in propelling the medication management systems industry. These technologies ensure seamless medication information integration, enhancing communication among healthcare providers, pharmacies, and patients, and guaranteeing accurate and timely medication management.

The medication management systems market is categorized based on software type, deployment mode, end-use, and region.

The market categorizes software types into clinical decision support system solutions (CDSS), inventory management and supply chain management software, computerized physician order entry (CPOE), diversion medication management, administration software, assurance system software, and other software types. In 2023, the clinical decision support system solutions (CDSS) segment led the revenue generation with USD 1.1 billion. CDSS solutions aim to reduce medication errors by offering healthcare professionals real-time, evidence-based guidance during medication prescribing and dispensing. These systems can notify providers about potential drug interactions, allergies, and contraindications, thus averting harmful mistakes. Given the persistent concern of medication errors in healthcare, the rising adoption of CDSS in medication management underscores its growing importance.

The medication management systems market classifies deployment modes into cloud-based, on-premises, and web-based solutions. In 2023, the cloud-based segment led the market with a 48% share. Cloud-based medication management systems provide unmatched scalability. This allows healthcare providers, from small clinics to expansive hospital networks, to adjust their services based on demand without hefty upfront infrastructure investments. Such adaptability is a primary reason for the surge in cloud-based solution adoption.

Moreover, cloud-based systems negate the need for costly on-premises hardware, maintenance, and IT support, translating to substantial savings for healthcare providers. Organizations can transition to a subscription-based model, paying solely for the services they utilize, rather than investing in physical servers and software licenses. This financial advantage, especially appealing to smaller providers or those on tight budgets, is set to further propel the segment's growth in the market.

In 2023, North America medication management systems market accounted for a substantial USD 1.7 billion, with projections indicating a CAGR of 9.5% from 2024 to 2032. North America, and the U.S. in particular, boasts one of the globe's most sophisticated healthcare infrastructures. This advanced setup, coupled with a trend of early adoption of innovative solutions like medication management systems, underscores market growth. The region's high prevalence of chronic diseases, necessitating intricate medication regimens, further emphasizes the importance of these systems in ensuring adherence and minimizing medication errors.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising medication errors and need for patient safety
      • 3.2.1.2 Growing adoption of healthcare IT solutions
      • 3.2.1.3 Increasing hospital and pharmacy automation
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High implementation and maintenance costs
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Key market trends
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis
  • 3.9 Gap analysis
  • 3.10 Future market trends

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Software Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Clinical decision support system solutions (CDSS)
  • 5.3 Inventory management and supply chain management software
  • 5.4 Computerized physician order entry (CPOE)
  • 5.5 Diversion medication management
  • 5.6 Administration software
    • 5.6.1 Barcode medication administration record
    • 5.6.2 Electronic medication administration record
  • 5.7 Assurance system software
  • 5.8 Other software types

Chapter 6 Market Estimates and Forecast, By Deployment Mode, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Cloud-based
  • 6.3 On-premise
  • 6.4 Web-based

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Pharmacies
  • 7.4 Ambulatory surgical centers
  • 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
    • 8.3.7 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Becton, Dickinson and Company
  • 9.2 Bluesight
  • 9.3 Capsa Healthcare
  • 9.4 eAgile Inc.
  • 9.5 Epic Systems Corporation
  • 9.6 GE HealthCare Technologies Inc.
  • 9.7 GUARDIAN RFID
  • 9.8 Impinj, Inc.
  • 9.9 MCKESSON CORPORATION
  • 9.10 Omnicell, Inc.
  • 9.11 Oracle Corporation
  • 9.12 RMS Omega
  • 9.13 Swisslog Healthcare
  • 9.14 Veradigm LLC
  • 9.15 Yankee Alliance LLC.